TNNT2 and cancer: TNNT2 is exclusively expressed in cardiac muscles, and it releases into the circulation by reflecting the extent of myocardial injury in acute coronary syndrome, myocarditis, cardiomyopathy, and anti-cancer therapy-induced cardiotoxicity (11, 14).